MARKET

CYRX

CYRX

Cryoport
NASDAQ

Real-time Quotes | Nasdaq Last Sale

63.03
+1.47
+2.39%
After Hours: 63.03 0 0.00% 16:54 05/07 EDT
OPEN
62.57
PREV CLOSE
61.56
HIGH
65.50
LOW
61.76
VOLUME
324.90K
TURNOVER
--
52 WEEK HIGH
84.97
52 WEEK LOW
18.88
MARKET CAP
2.88B
P/E (TTM)
-32.6428
1D
5D
1M
3M
1Y
5Y
Cryoport, LabConnect Offering Logistics Support To Triumvira Immunologics Clinical Trial
MT Newswires · 2d ago
BRIEF-LabConnect And Cryoport Announce Partnership
reuters.com · 2d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Benzinga · 3d ago
Sector Update: Health Care
MT Newswires · 3d ago
Needham Maintains Buy on CryoPort, Raises Price Target to $77
Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $73 to $77.
Benzinga · 3d ago
--Needham Adjusts Price Target on Cryoport to $77 From $73, Maintains Buy Rating
MT Newswires · 3d ago
--UBS Adjusts Cryoport's Price Target to $88 From $84, Maintains Buy Rating
MT Newswires · 4d ago
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
Zacks.com · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CYRX. Analyze the recent business situations of Cryoport through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CYRX stock price target is 76.13 with a high estimate of 84.00 and a low estimate of 70.00.
EPS
Institutional Holdings
Institutions: 245
Institutional Holdings: 43.88M
% Owned: 96.16%
Shares Outstanding: 45.64M
TypeInstitutionsShares
Increased
69
3.11M
New
49
3.39M
Decreased
61
3.51M
Sold Out
20
961.36K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Courier, Postal, Air Freight & Land-based Logistics
+1.37%
Freight & Logistics Services
+1.15%
Key Executives
Chairman/President/Chief Executive Officer/Director
Jerrell Shelton
Chief Financial Officer/Treasurer
Robert Stefanovich
Senior Vice President/Chief Scientific Officer
Mark Sawicki
Lead Director/Independent Director
Richard Berman
Independent Director
Linda Baddour
Independent Director
Daniel Hancock
Independent Director
Richard Schwalm
Independent Director
Robert Hariri
Independent Director
Ram Jagannath
Independent Director
Ramkumar Mandalam
Independent Director
Edward Zecchini
No Data
About CYRX
Cryoport, Inc. (Cryoport), is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Through its products and services, the Company enables its clients to ship, store and deliver cellular-based materials and drug products as well as other life sciences commodities in a precise, defined temperature-controlled state. The Company’s advanced platform is comprised of comprehensive and technology-centric systems and solutions are designed to support the global high-volume distribution of commercial biologic and cell-based products and therapies regulated by the United States Food and Drug Administration (FDA) and other international regulatory bodies for distribution in the Americas, Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions. The Company’s subsidiaries include Cryoport Systems, Inc., MVE Biological Solutions, CRYOPDP and Cryogene Partners.

Webull offers kinds of CryoPort Inc stock information, including NASDAQ:CYRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CYRX stock methods without spending real money on the virtual paper trading platform.